ArticleCureus2026
An Evolving Clinical Phenotype Preceding the Diagnosis of Eosinophilic Granulomatosis With Polyangiitis: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Eosinophilic granulomatosis with polyangiitis (EGPA), formerly known as Churg-Strauss syndrome, is a rare antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis characterised by eosinophilic inflammation, granulomatous disease and necrotising small- to medium-vessel vasculitis. Diagnosis is often delayed because clinical manifestations evolve gradually and mimic more common respiratory, infectious or inflammatory conditions. We describe a 53-year-old woman with recurrent hospital admissions over a two-year period and persistent low-positive ANCA serology, during which there was initially insufficient clinical evidence of systemic vasculitis. She subsequently presented with respiratory symptoms, palpable purpura, oral ulceration and nasal crusting. Investigations demonstrated peripheral eosinophilia (9.1 × 10⁹/L) and bilateral pulmonary inflammatory infiltrates. The emergence of eosinophilia alongside pulmonary, cutaneous and upper airway involvement provided sufficient clinical evidence to support a diagnosis of EGPA. High-dose corticosteroid therapy resulted in rapid clinical improvement and normalisation of the eosinophil count. This case highlights how EGPA may evolve over time before sufficient clinical features emerge to support the diagnosis. Recurrent non-specific presentations associated with eosinophilia and evolving multisystem involvement should prompt continued clinical reassessment, even when previous investigations have been inconclusive.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.